Vasomax oral phentolamine data

Preliminary results of a dose-response, multi-center German Phase II trial with Vasomax demonstrated an optimum dose, and showed improvement in erectile function with a minimum of side-effects, compared to placebo.

A total of 177 patients with up to three years of erectile dysfunction due to vascular conditions were randomized to receive placebo, or 20, 40 or 60 mg of drug. Patients attempted to achieve intercourse on three occasions. Preliminary analysis of data indicates that the 40 mg dose provided the best balance between efficacy and safety. ...